Sangamo Therapeutics, Inc. (NASDAQ:SGMO) Gained 15.61% in Premarket
The insider ownership percentage is the key indicator, can be used by investors, to measure the outlook of senior management has on their company. Insider ownership for the SGMO is 0.20%. Institutional ownership refers to the ownership stake in a company that is held by large financial organizations, pension funds or endowments. The Institutional ownership for the SGMO is 58.10%.
Insider trading is the buying or selling of any publicly traded company’s stock and this can be done by someone who has non-public, material information about that SGMO. Insider trading can be illegal or legal depending on when the insider makes the trade. It is illegal when the material information is still non-public. The insider transactions of the company (6-month change in insider ownerships) for the Sangamo Therapeutics, Inc. (NASDAQ:SGMO) is -11.72%.
Institutional transactions is the amount of a Sangamo Therapeutics, Inc. (NASDAQ:SGMO)’s available stock owned by mutual or pension funds, insurance companies, investment firms, private foundations, endowments or other large entities that actually manage the funds on the behalf of others, so its an interesting element for the traders to note it, and the Institutional ownership for the SGMO is 2.59%.
A Healthcare sector firm, Sangamo Therapeutics, Inc. (NASDAQ:SGMO) stock shed -1.81% on Friday and when day-trade ended the stock finally concluded at $11.40 and number of shares that changed hands during the day are 2.19 Million. The number of shares SGMO stock currently held by all its shareholders are 113.01 and floated shares, the number of shares are available for trading in an open market on last trading day are 113.01. The average volume of shares for 3 months is 1640.75 and SGMO stock value has moved between $6.26 – 19.32 in last one year.
The Sangamo Therapeutics, Inc. (NASDAQ:SGMO)’s latest earnings date is 8/7/2019. The Gross margin is the difference between the revenue and the cost of goods sold (COGS), divided by revenue. In other words, Gross Margin is a percentage value, while Gross Profit is a monetary value. Sangamo Therapeutics, Inc. (NASDAQ:SGMO) stock has gained -0.70% in 2019 to date.
Sangamo Therapeutics, Inc. (NASDAQ:SGMO)’s monthly stock performance is 22.58%, the quarterly performance is -6.10%, the half year performance is calculated as 3.26%. The yearly performance of SGMO is -25.49%.
The higher the volatility, the riskier the security. For example, when the stock market rises and falls more than one percent over a sustained period of time, it is called a “volatile” market, if the stock price stays relatively stable, the security has low volatility. The Sangamo Therapeutics, Inc. (NASDAQ:SGMO) weekly volatility is measured as 5.37% and monthly volatility measured as 4.84%.
Return on assets (ROA) is a main indicator of how profitable a company is relative to its total assets. SGMO return on assets is -15.30%, the return on equity (ROE) of the Sangamo Therapeutics, Inc. (NASDAQ:SGMO) is -24.70%, while the most important return on investment is calculates as a percentage and is typically used for personal financial decisions, and SGMO return on investment is -19.60%.
The price to sales ratio is 16.12, and price to book ratio is 3.55, price to cash per share ration is 3.67.
Analysts mean target price for Sangamo Therapeutics, Inc. (NASDAQ:SGMO) is $23.50 while analysts mean recommendation is 2.10. The current share price indicates that stock is -40.78% away from its one year high and is moving 82.11% ahead of its 52-week low. SGMO’s distance from 20 day simple moving average is 15.09% and distance from 50-Day simple moving average is 11.62%.